Hennessy Capital Investment Corp. VII
NASDAQ:HVIIFinancial - Conglomerates
-$0.01 today
- Market cap
- $116.06M
- Beta
- 0.05
- P/E (TTM)
- 61.2
- EPS (TTM)
- $0.17
Volume 10.51M
Average 0.05M
HVII Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Hennessy Capital Investment Corp. VIINASDAQ: HVII
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) declines year over year
Q1 FY2026 weighted avg shares (diluted) of 19M shares fell 27.0% year over year. Sequentially, it rose 6.1% from the prior quarter.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 17.91M USD
- Year-over-year change
- -31.2%
- 1-year CAGR
- -31.2%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.91M | -31.2% |
| FY2024 | 2024-12-31 | 26.02M | — |
Weighted Avg Shares (Diluted) vs competitors
How HVII compares with its peers on the latest reported figures
- HVII's LTM Mar 2026 weighted avg shares (diluted) of 20.48M shares is the 10th highest of the 11 companies compared; the peer median is 24.04M shares.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| FY2025 | 34.03M | — | — | |
BEAGBold Eagle Acquisition Corp. | LTM Mar 2026 | 27.18M | -7.0% | -5.3% |
POLEAndretti Acquisition Corp. II | LTM Mar 2026 | 26.26M | +10.1% | — |
| LTM Mar 2026 | 25.76M | — | — | |
| LTM Mar 2026 | 25.13M | +96.3% | — | |
DRDBRoman DBDR Acquisition Corp. II | LTM Mar 2026 | 22.94M | — | — |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | LTM Mar 2026 | 22.75M | — | — |
OACCOaktree Acquisition Corp. III Life Sciences | LTM Mar 2026 | 21.89M | — | — |
| LTM Mar 2026 | 21.4M | -13.9% | -18.8% | |
| LTM Mar 2026 | 20.48M | — | — | |
| LTM Mar 2026 | 19.74M | -14.9% | — | |
| Peer median (excluding HVII) | 24.04M | -7.0% | -12.0% | |
Competitors are the stored peer set for HVII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Gross Margin | — | — |
| Research & Development | 0 | 0 |
| Selling, General & Admin | 47.95K | 3.66M |
| Operating Expenses | 47.95K | 3.66M |
| Depreciation & Amortization | 0 | 0 |
| EBITDA | (47.95K) | (3.66M) |
| EBITDA Margin | — | — |
| Operating Income | (47.95K) | (3.66M) |
| Operating Margin | — | — |
| Interest Income | 0 | 7.34M |
| Interest Expense | 0 | 0 |
| Other Income / Expenses | 0 | 7.34M |
| Income Before Tax | (47.95K) | 3.69M |
| Pre-Tax Margin | — | — |
| Income Tax Expense | 0 | 0 |
| Net Income | (47.95K) | 3.69M |
| Net Margin | — | — |
| EPS (Basic) | (0.00) | 0.15 |
| EPS (Diluted) | (0.00) | 0.15 |
| Weighted Avg Shares | 26.02M | 17.91M |
| Weighted Avg Shares (Diluted) | 26.02M | 17.91M |
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
Intrinsic Alpha fair value
Locked
Current Price
$4.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.